These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15586420)

  • 1. International regional collaborations are paying off.
    Mitchell P
    Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 3. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA launches two research centers with academia.
    Fox JL
    Nat Biotechnol; 2014 Jul; 32(7):601. PubMed ID: 25004209
    [No Abstract]   [Full Text] [Related]  

  • 5. Chinese biotech: the need for innovation and higher standards.
    Wong GH
    Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germany reattempts to spark innovation.
    Habeck M
    Nat Biotechnol; 2004 Mar; 22(3):257-8. PubMed ID: 14990939
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 9. Singapore R&D and globetrotting.
    Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
    Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
    [No Abstract]   [Full Text] [Related]  

  • 10. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
    Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
    Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
    [No Abstract]   [Full Text] [Related]  

  • 11. The promise of the East: India and China as R&D options.
    Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
    Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
    [No Abstract]   [Full Text] [Related]  

  • 12. Paths to entrepreneurship in the life sciences.
    Mehta S
    Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
    [No Abstract]   [Full Text] [Related]  

  • 13. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 14. New biotech oasis?
    Sheridan C
    Nat Biotechnol; 2005 Aug; 23(8):919. PubMed ID: 16114121
    [No Abstract]   [Full Text] [Related]  

  • 15. Exiting this year and into the next.
    Nat Biotechnol; 2005 Dec; 23(12):1451. PubMed ID: 16333272
    [No Abstract]   [Full Text] [Related]  

  • 16. France to focus on a few biotech clusters.
    Balcon E
    Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of academic medicine for innovations in development of drugs and biomedicine technology].
    Manns MP
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1993-4. PubMed ID: 24065403
    [No Abstract]   [Full Text] [Related]  

  • 18. Superscience me!
    Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
    [No Abstract]   [Full Text] [Related]  

  • 19. Earlier stage biotechs attract partners.
    Ratner M
    Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
    [No Abstract]   [Full Text] [Related]  

  • 20. Swedish roadtrip.
    Herrera S
    Nat Biotechnol; 2006 Jan; 24(1):15. PubMed ID: 16475247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.